Isolation and assessment of the effectiveness of bacteriophages isolated from marine environment and their effect in the control of bacterial growth
Keywords:
Phagotherapy, Bacteriophage, Vibrio fluvialis, Artemia sp.Abstract
The indiscriminate use of antibiotics has led to the emergence of antibiotic-resistant bacteria. Therefore, the search for new treatments to control pathogenic bacterial populations and improve the survival and growth of aquatic organisms is gaining importance in recent years. Under these circumstances, the use of bacteriophages as therapeutic agents appears as an alternative for the control of diseases in aquaculture. In this survey, tests carried out using Artemia sp. nauplii, which were infected with Vibrio fluvialis Strain 1, showed a 90% survival rate compared to the control in which only 52% was obtained; the use of phage at the beginning of the infection showed a greater survival among these microcrustaceans. Finally, the treatment with phage proved to be effective for the control of mortalities caused by the bacterium V. fluvialis using Artemia sp.
Downloads
Metrics
References
Alagappan K, Deivasigamani D, Somasundaram S, Kumaran S. 2010. Occurrence of Vibrio parahaemolyticus and its specific phages from shrimp ponds in east coast of india. Curr. Microbiol. 61(4): 235 - 240.
Almeida A, Cunha A, Gomes N, Alvens E, Costa L, Faustino m. 2009. phage therapy and photodynamics therapy: Low environmental impact approaches to inactivate microorganism in fish farming plants. Mar Drugs. 7: 268 - 313.
Bradley D. 1965. The Isolation and morphology of Some New Bacteriophages Specific for Bacillus and Acetobacter species. J. Gen. microbiol.41: 233 - 241.
Cabello F. 2006. Heavy use of prophylactic antibiotics in aquaculture: a growing problem for human and animal health and for the environment. Environmental microbiology. 8 (7): 1137 - 1144.
Chow M, Rouf A. 1983. Isolation and partial characterization of two Aeromonas hydrophila Bacteriophages. Applied and Environmental microbiology. 45(5): 1670 - 1676.
Dopazo C, Lemos M, Lodeiros C, Bolinches J, Barja J, Toranzo A. 1988. inhibitory activity of antibiotic-producing marine bacteria against fish pathogens. Journal of Applied Bacteriology.65: 97 - 101.
FAO/OIE/WHO. 2006. Antimicrobial use in aquaculture and antimicrobial resistance. Report of a Joint FAO/OIE/WHO Expert Consultation on antimicrobial use in aquaculture and antimicrobial resistance. Department of Food Safety, Zoonoses and Foodborne Diseases. World Health Organization, Geneva, Switzerland, Seoul, Republic of Korea. www.who.int/foodborne_disease/resistance/en/
Hsu C, Lo C, Liu J, Lin C. 2000. Control of the eel Anguilla japonica pathogens Aeromonas hydrophila and Edwarsiella tarda by bacteriophages. Journal of the Fisheries Society of Taiwan. 27: 21 - 31.
Hyman P, Abedon S. 2010. Bacteriophage host range and bacterial resistance. Advances in Applied. microbiology.70: 217 - 248.
Jun J, Kim J, Shin S, Han J, Chai J, Park S. 2013. Protective effects of the Aeromonas phages pAh1-C and pAh6-C against mass mortality of the cyprinid loach (Misgurnus anguillicaudatus) caused by Aeromonas hydrophila. Aquaculture. 416-417: 289 - 295.
Lomeli C O. 2011. La fagoterapia como estrategia para reducir la mortalidad por vibriosis en larvas de camarón blanco Litopenaeus vannamei. maestría en manejo de recursos marinos Thesis, instituto politécnico Nacional. Centro interdisciplinario de Ciencias Marinas., La Paz, B.C.S., México. 98 pp.
Martínez S, Hipolito A. 2013. Efficacy of phage therapy to prevent mortality during the Vibriosis of brine shrimp. Aquaculture. 1(1): 120 - 124.
Nakai T, Park S. 2002. Bacteriophage therapy of infectious diseases in aquaculture. res microbiol. 153(1): 13 - 18.
Park S, Shimamura I, Fukunaga M, Mori K, Nakai T. 2000. Isolation of bacteriophages specific to a fish pathogen Pseudomona plecoglossicida as a candidate for disease control. Applied Environmental microbiology.66: 1416 - 1422.
Paterson R, Grinyer I, Dermott L. 1969. isolation and preliminary characterization of some Aeromonas salmonicida bacteriophages. J. Fish. Res. Board Can. 26: 629 - 632.
Phumkhachorn P, Rattanachaikunsopon p. 2010. isolation and partial characterization of a bacteriophage infecting the shrimp pathogen Vibrio harveyi. African Journal of microbiology research. 4(16): 1794 - 1800.
Ronda C, Vásquez M, López R. 2003. Los bacteriófagos como herramienta para combatir infecciones en Acuicultura. revista AquaTiC. 18: 3 - 10.
Segundo A, Hernández B, López V, Torres O. 2010. Los bacteriófagos como una alternativa en el tratamiento de enfermedades infecciosas bacterianas (Fagoterapia). Revista Mexicana de Ciencias Farmacéuticas. 4: 117 - 126.
Stenholm A, Dalsgaard I, Middelboe m. 2008. isolation and characterization of bacteriophages infecting the fish pathogen Flavobacteriumpsychrophilum. Applied and Environmental microbiology.74(13): 4070 - 4078.
Walakira K. 2008. Discovery, isolation and characterization of bacteriophages specific for Edwarsiella ictaluri. Thesis of master of Science. Auburn University. United States of America.
Wu J-L, Hui-Ming Lin, Lu Jan, Ya-Li H, Lu-His Chang. 1981. Biological control of fish pathogen, Aeromonas hydrophila by bacteriophage, AH1. Fish pathology.15(3-4): 271 - 276.
Yin R, Chi W, Fen Y, Chang-Shin L. 2012. Characterization of a new phage, termed ØA318, which is specific for Vibrio alginolyticus. Arch. Virol. 157: 917 - 926.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 Instituto del Mar del Perú
This work is licensed under a Creative Commons Attribution 4.0 International License.
© Bol Inst Mar Perú. La revista retiene los derechos patrimoniales de los autores con la finalidad de garantizar el acceso abierto de los manuscritos.
Todos los manuscritos publicados en la revista se distribuyen bajo la licencia “Creative Commons Atribución - NoComercial - CompartirIgual 4.0 Internacional” (CC BY-NC-SA 4.0). Implica que autores y lectores pueden de forma gratuita descargar, almacenar, copiar, redistribuir, remezclar, transformar o generar obras derivadas a partir del manuscrito, siempre y cuando mencionen la fuente primaria de publicación y la autoría del manuscrito, así como que se realice sin fines comerciales y se distribuya bajo la misma licencia que el original. Puede consultar desde aquí la versión informativa y el texto legal de la licencia.
